Heart Failure

Heart failure occurs when the heart cannot pump as much blood as the body requires. This ineffective pumping can lead to enlargement of the heart as the myocardium works harder pump the same amount of blood. Heart failure may be caused by defects in the myocardium, such as an a heart attack infarct, or due to structural issues such as severe heart valve regurgitation. Heart failure can be divided into HF with preserved ejection fraction (HFpEF), and HF with reduced ejection fraction (HFrEF). The disease is further divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or hemodynamic support from a left ventricular assist device (LVAD).

LBBAP limits hospital readmissions after TAVR
Left bundle branch area pacing is associated with better long-term outcomes than traditional right ventricular pacing when patients require PPMI after TAVR, according to new research in Heart Rhythm.
FDA approves Boston Scientific leads for left bundle branch area pacing
Boston Scientific's INGEVITY+ pacing leads were originally approved by the FDA back in 2019. They can now be used for LBBAP, a new alternative to biventricular pacing.
JACC editor excited by progress during a 'very important moment' for cardiology
Harlan Krumholz, MD, editor-in-chief of the Journal of the American College of Cardiology, explains some of the key technology and treatment trends he has his eyes on.
FDA approves Biotronik lead, catheter for left bundle branch area pacing
LBBAP is a relatively new alternative to biventricular pacing. The FDA's decision was based largely on data from the BIO-CONDUCT clinical trial.
Surgeons make history, perform world’s first fully robotic heart transplant
The procedure, which lasted roughly two and half hours, was performed on a 16-year-old patient with end-stage heart failure.

Empagliflozin provides consistent benefits for HFpEF patients

Researchers took a fresh look at data from the EMPEROR-Preserved trial, sharing their findings in Circulation.

November 18, 2021

Stem cell therapy for heart failure lowers risk of adverse outcomes

“Cell therapy has the potential to change how we treat heart failure,” one researcher said.

November 16, 2021

New risk calculator detects TEER patients who may need to be readmitted for HF

Once the tool's performance is properly validated, it could help clinicians deliver better patient care and result in significant cost savings for health systems.

November 12, 2021

Some cancer immunotherapies may increase the risk of myocarditis

The study's authors tracked data from facilities in 11 different countries, examining imaging findings from patients with ICI-related myocarditis.

November 8, 2021

Sacubitril/valsartan no better than valsartan alone for advanced heart failure

"Every clinical outcome that we measured favored treatment with valsartan alone," one researcher said.

November 4, 2021

Using pulmonary artery pressure monitoring to manage obese HF patients leads to strong outcomes

Researchers examined data from the CardioMEMS Post Approval Study, sharing their findings in JACC: Heart Failure.

November 3, 2021

Diabetes with cardiomyopathy associated with heightened heart failure risk

At this time, however, clinicians lack an intervention that specifically targets this combination of complications.

October 28, 2021

Scenes from the pandemic: Telehealth a perfect fit for treating heart failure

One large health system actually treated more heart failure patients during the pandemic than it had in previous years.

October 22, 2021

Heart Failure

LBBAP limits hospital readmissions after TAVR

FDA approves Boston Scientific leads for left bundle branch area pacing

JACC editor excited by progress during a 'very important moment' for cardiology

FDA approves Biotronik lead, catheter for left bundle branch area pacing

Surgeons make history, perform world’s first fully robotic heart transplant